Summary
WHO guidance focused specifically on large multi-modal generative AI models (LMMs) in health, outlining risks, ethical principles, and governance measures for their design, deployment and oversight.
Healthcare Implications
It provides concrete recommendations for governments, regulators, health systems and developers on how to evaluate, procure and use LMM-based tools in clinical care, public health and research while managing safety, bias, privacy and accountability risks.